-
Je něco špatně v tomto záznamu ?
The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study
C. Ruoff, F. Pizza, LM. Trotti, K. Sonka, S. Vandi, J. Cheung, S. Pinto, M. Einen, N. Simakajornboon, F. Han, P. Peppard, S. Nevsimalova, G. Plazzi, D. Rye, E. Mignot,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural
Grantová podpora
K23 NS083748
NINDS NIH HHS - United States
R01 NS089719
NINDS NIH HHS - United States
T32 HL110952
NHLBI NIH HHS - United States
NLK
Free Medical Journals
od 2007 do Před 6 měsíci
PubMed Central
od 2007 do Před 1 rokem
PubMed
29198301
DOI
10.5664/jcsm.6882
Knihovny.cz E-zdroje
- MeSH
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- narkolepsie diagnóza MeSH
- polysomnografie metody statistika a číselné údaje MeSH
- reprodukovatelnost výsledků MeSH
- retrospektivní studie MeSH
- senzitivita a specificita MeSH
- věkové faktory MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Research Support, N.I.H., Extramural MeSH
STUDY OBJECTIVES: To examine repeatability of Multiple Sleep Latency Test (MSLT) results in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2) according to the criteria of the International Classification of Sleep Disorders, Third Edition (ICSD-3). METHODS: Repeatability of the MSLT was retrospectively evaluated in NT1 (n = 60) and NT2 (n = 54) cases, and controls (n = 15). All subjects had documented HLA-DQB1*06:02 status and/or hypocretin-1 levels from cerebrospinal fluid. All subjects had undergone 2 MSLTs (≥ 1 meeting ICSD-3 criteria for narcolepsy). Repeatability was explored in children versus adults and in those on versus not on medication(s). Subsample and multivariate analysis were performed. RESULTS: Both MSLTs in unmedicated patients were positive for narcolepsy in 78%, 18%, and 7% of NT1, NT2, and controls, respectively. NT2 cases changed to idiopathic hypersomnia or to a negative MSLT 26% and 57% of the time, respectively. Although NT1 cases were 10 to 14 times more likely to demonstrate a second positive MSLT compared to NT2 cases (P < 10-5) and controls (P < 10-4), respectively, NT2 cases were not significantly different from controls (P = .64). Medication use (P = .009) but not adult versus children status (P = .85) significantly decreased the likelihood of a repeat positive MSLT. CONCLUSIONS: In a clinical setting, a positive MSLT for narcolepsy is a more reproducible and stable feature in NT1 than NT2. The retrospective design of this study hinders interpretation of these data, as there are many different, and possibly opposing, reasons to repeat a MSLT in NT1 versus NT2 (ie, ascertainment bias). Additional systematic MSLT repeatability studies independent of confounds are ideally needed to confirm these findings.
Department of Neurology 1st Medical Faculty Charles University Prague Czeck Republic
Department of Neurology Emory Sleep Center Emory University School of Medicine Atlanta Georgia
Department of Preventive Medicine University of Madison Wisconsin Madison Wisconsin
Department of Pulmonary Medicine Peking University People's Hospital Beijing China
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045578
- 003
- CZ-PrNML
- 005
- 20200115084651.0
- 007
- ta
- 008
- 200109s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5664/jcsm.6882 $2 doi
- 035 __
- $a (PubMed)29198301
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Ruoff, Chad $u Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California.
- 245 14
- $a The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study / $c C. Ruoff, F. Pizza, LM. Trotti, K. Sonka, S. Vandi, J. Cheung, S. Pinto, M. Einen, N. Simakajornboon, F. Han, P. Peppard, S. Nevsimalova, G. Plazzi, D. Rye, E. Mignot,
- 520 9_
- $a STUDY OBJECTIVES: To examine repeatability of Multiple Sleep Latency Test (MSLT) results in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2) according to the criteria of the International Classification of Sleep Disorders, Third Edition (ICSD-3). METHODS: Repeatability of the MSLT was retrospectively evaluated in NT1 (n = 60) and NT2 (n = 54) cases, and controls (n = 15). All subjects had documented HLA-DQB1*06:02 status and/or hypocretin-1 levels from cerebrospinal fluid. All subjects had undergone 2 MSLTs (≥ 1 meeting ICSD-3 criteria for narcolepsy). Repeatability was explored in children versus adults and in those on versus not on medication(s). Subsample and multivariate analysis were performed. RESULTS: Both MSLTs in unmedicated patients were positive for narcolepsy in 78%, 18%, and 7% of NT1, NT2, and controls, respectively. NT2 cases changed to idiopathic hypersomnia or to a negative MSLT 26% and 57% of the time, respectively. Although NT1 cases were 10 to 14 times more likely to demonstrate a second positive MSLT compared to NT2 cases (P < 10-5) and controls (P < 10-4), respectively, NT2 cases were not significantly different from controls (P = .64). Medication use (P = .009) but not adult versus children status (P = .85) significantly decreased the likelihood of a repeat positive MSLT. CONCLUSIONS: In a clinical setting, a positive MSLT for narcolepsy is a more reproducible and stable feature in NT1 than NT2. The retrospective design of this study hinders interpretation of these data, as there are many different, and possibly opposing, reasons to repeat a MSLT in NT1 versus NT2 (ie, ascertainment bias). Additional systematic MSLT repeatability studies independent of confounds are ideally needed to confirm these findings.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a narkolepsie $x diagnóza $7 D009290
- 650 _2
- $a polysomnografie $x metody $x statistika a číselné údaje $7 D017286
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a senzitivita a specificita $7 D012680
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 700 1_
- $a Pizza, Fabio $u IRCCS Istituto delle Scienze Neurologiche, ASL di Bologna, Bologna, Italy. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
- 700 1_
- $a Trotti, Lynn Marie $u Department of Neurology, Emory Sleep Center, Emory University School of Medicine, Atlanta, Georgia.
- 700 1_
- $a Sonka, Karel $u Department of Neurology, 1st Medical Faculty, Charles University, Prague, Czeck Republic.
- 700 1_
- $a Vandi, Stefano $u IRCCS Istituto delle Scienze Neurologiche, ASL di Bologna, Bologna, Italy. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
- 700 1_
- $a Cheung, Joseph $u Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California.
- 700 1_
- $a Pinto, Swaroop $u Sleep Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Division of Pulmonology and Sleep Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
- 700 1_
- $a Einen, Mali $u Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California.
- 700 1_
- $a Simakajornboon, Narong $u Sleep Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Division of Pulmonology and Sleep Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
- 700 1_
- $a Han, Fang $u Department of Pulmonary Medicine, Peking University People's Hospital, Beijing, China.
- 700 1_
- $a Peppard, Paul $u Department of Preventive Medicine, University of Madison Wisconsin, Madison, Wisconsin.
- 700 1_
- $a Nevsimalova, Sona $u Department of Neurology, 1st Medical Faculty, Charles University, Prague, Czeck Republic.
- 700 1_
- $a Plazzi, Giuseppe $u IRCCS Istituto delle Scienze Neurologiche, ASL di Bologna, Bologna, Italy. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
- 700 1_
- $a Rye, David $u Department of Neurology, Emory Sleep Center, Emory University School of Medicine, Atlanta, Georgia.
- 700 1_
- $a Mignot, Emmanuel $u Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California.
- 773 0_
- $w MED00188111 $t Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine $x 1550-9397 $g Roč. 14, č. 1 (2018), s. 65-74
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29198301 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200115085024 $b ABA008
- 999 __
- $a ok $b bmc $g 1483846 $s 1084251
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 14 $c 1 $d 65-74 $e 20180115 $i 1550-9397 $m Journal of clinical sleep medicine $n J Clin Sleep Med $x MED00188111
- GRA __
- $a K23 NS083748 $p NINDS NIH HHS $2 United States
- GRA __
- $a R01 NS089719 $p NINDS NIH HHS $2 United States
- GRA __
- $a T32 HL110952 $p NHLBI NIH HHS $2 United States
- LZP __
- $a Pubmed-20200109